Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;104(1):49-53.
doi: 10.1016/j.contraception.2021.03.025. Epub 2021 Mar 28.

Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models

Courtney Kerestes  1 , Sarah Murayama  2 , Jasmine Tyson  3 , Melissa Natavio  3 , Elisabeth Seamon  2 , Shandhini Raidoo  3 , Lea Lacar  2 , Emory Bowen  3 , Reni Soon  3 , Ingrida Platais  4 , Bliss Kaneshiro  3 , Paris Stowers  3
Affiliations

Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models

Courtney Kerestes et al. Contraception. 2021 Jul.

Abstract

Objective: To demonstrate the effectiveness of medication abortion with the implementation of telemedicine and a no-test protocol in response to the COVID-19 pandemic.

Study design: This is a retrospective cohort study of patients who had a medication abortion up to 77 days gestation at the University of Hawai'i between April and November 2020. Patients had the option of traditional in clinic care or telemedicine with either in clinic pickup or mailing of medications. During this time, a no-test protocol for medication abortion without prior labs or ultrasound was in place for eligible patients. The primary outcome was the rate of successful medication abortion without surgical intervention. Secondary outcomes included abortion-related complications.

Results: A total of 334 patients were dispensed mifepristone and misoprostol, 149 (44.6%) with telemedicine with in-person pickup of medications, 75 (22.5%) via telemedicine with medications mailed, and 110 (32.9%) via traditional in person visits. The overall rate of complete medication abortion without surgical intervention was 95.8%, with success rates of 96.8, 97.1, and 93.6% for the clinic pickup, mail, and clinic visit groups, respectively. Success for those without an ultrasound performed prior to the procedure was 96.6%, compared to 95.5% for those with ultrasound. We obtained follow-up data for 87.8% of participants.

Conclusions: Medication abortion was safe and effective while offering multiple modes of care delivery including telemedicine visits without an ultrasound performed prior to dispensing medications.

Implications: Incorporating telemedicine and a no-test protocol for medication abortion is safe and has the potential to expand access to abortion care. All care models had low rates of adverse events, which contradicts the idea that the Risk Evaluation and Mitigation Strategyincreases the safety of medication abortion.

Keywords: COVID-19; Medication abortion; Mifepristone; Misoprostol; Telemedicine; Ultrasound.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Methods of providing medication abortion to patients at the University of Hawai‘i between April and November 2020. US, ultrasound
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Contreras C.M., Metzger G.A., Beane J.D., Dedhia P.H., Ejaz A., Pawlik T.M. Telemedicine: patient-provider clinical engagement during the COVID-19 pandemic and beyond. J Gastrointest Surg. 2020;24:1692–1697. - PMC - PubMed
    1. Ramaswamy A., Yu M., Drangsholt S., Ng E., Culligan P.J., Schlegel P.N., Hu J.C. Patient satisfaction with telemedicine during the COVID-19 pandemic: retrospective cohort study. J Med Internet Res. 2020;22:e20786. - PMC - PubMed
    1. Grossman D., Grindlay K. Safety of medical abortion provided through telemedicine compared with in person. Obstet gynecol. 2017;130:778–782. - PubMed
    1. Grossman D., Grindlay K., Buchacker T., Lane K., Blanchard K. Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet gynecol. 2011;118:296–303. - PubMed
    1. Raymond E., Chong E., Winikoff B., Platais I., Mary M., Lotarevich T., et al. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States. Contraception. 2019;100:173–177. - PubMed